Suppression of breast cancer progression by FBXL16 via oxygen-independent regulation of HIF1 alpha stability
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yeon-Ju | - |
dc.contributor.author | Zhao, Yi | - |
dc.contributor.author | Myung, Jae Kyung | - |
dc.contributor.author | Yi, Joo Mi | - |
dc.contributor.author | Kim, Min-Jung | - |
dc.contributor.author | Lee, Su-Jae | - |
dc.date.accessioned | 2022-07-06T11:13:37Z | - |
dc.date.available | 2022-07-06T11:13:37Z | - |
dc.date.created | 2021-12-08 | - |
dc.date.issued | 2021-11-23 | - |
dc.identifier.issn | 2211-1247 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140303 | - |
dc.description.abstract | Triple-negative breast cancers (TNBCs) are characterized by high rates of recurrence and poor clinical outcomes. Deregulated E3 ligases are involved in breast cancer pathogenesis and progression, but the underlying mechanisms are unclear Here, we find that F-box and leucine-rich repeat protein 16 (FBXL16) acts as a tumor suppressor in TNBCs. FBXL16 directly binds to HIF1 alpha and induces its ubiquitination and degradation, regardless of the tumor microenvironment, resulting in blockade of the HIF1 alpha-mediated epithelial-mesenchymal transition (EMT) and angiogenesis features of breast cancer. In TNBCs, FBXL16 expression is downregulated by the p38/miR-135b-3p axis, and loss of FBXL16 expression restores HIF1 alpha-mediated metastatic features of breast cancer. Low expression of FBXL16 is associated with high-grade and lymph node-positive tumors and poor overall survival of breast cancer. Taken together, these findings demonstrate that modulation of FBXL16 expression may offer a favorable strategy for treatment of patients with metastatic breast cancer, including TNBCs. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.title | Suppression of breast cancer progression by FBXL16 via oxygen-independent regulation of HIF1 alpha stability | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Myung, Jae Kyung | - |
dc.contributor.affiliatedAuthor | Lee, Su-Jae | - |
dc.identifier.doi | 10.1016/j.celrep.2021.109996 | - |
dc.identifier.scopusid | 2-s2.0-85119501190 | - |
dc.identifier.wosid | 000722754700003 | - |
dc.identifier.bibliographicCitation | CELL REPORTS, v.37, no.8, pp.1 - 20 | - |
dc.relation.isPartOf | CELL REPORTS | - |
dc.citation.title | CELL REPORTS | - |
dc.citation.volume | 37 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 20 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | F-BOX PROTEINS | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | DEGRADATION | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | SUBTYPES | - |
dc.subject.keywordPlus | ALPHA | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | angiogenesis | - |
dc.subject.keywordAuthor | E3 ligase | - |
dc.subject.keywordAuthor | EMT | - |
dc.subject.keywordAuthor | FBXL16 | - |
dc.subject.keywordAuthor | TNBC | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.